Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0PW4C
|
||||
Former ID |
DNC001021
|
||||
Drug Name |
Niravoline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Phase 2 | [545439] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H25N3O3
|
||||
Canonical SMILES |
CN(C1C(CC2=CC=CC=C12)N3CCCC3)C(=O)CC4=CC(=CC=C4)[N+](=O<br />)[O-]
|
||||
InChI |
1S/C22H25N3O3/c1-23(21(26)14-16-7-6-9-18(13-16)25(27)28)22-19-10-3-2-8-17(19)15-20(22)24-11-4-5-12-24/h2-3,6-10,13,20,22H,4-5,11-12,14-15H2,1H3/t20-,22?/m0/s1
|
||||
InChIKey |
ZSDAQBWGAOKTSI-AIBWNMTMSA-N
|
||||
CAS Number |
CAS 130610-93-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Modulator | ||
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.